CTLA4 and cancer: Recently, immunotherapy targeting immunosuppressive proteins such as cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and programmed cell death 1 (PD-1) has provided more treatment options for cancer patients [41, 42].